Improving medication safety for nursing home residents prescribed psychotropic dr
提高疗养院居民精神药物处方的用药安全
基本信息
- 批准号:8634379
- 负责人:
- 金额:$ 11.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-12-01 至 2016-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAdverse eventAgingAntidepressive AgentsAntipsychotic AgentsApplications GrantsArtificial IntelligenceClinicalClinical ResearchCollaborationsComplementDataDeliriumDetectionDoctor of PhilosophyDoseDrug CombinationsDrug InteractionsEffectivenessElderlyEventFatigueFeasibility StudiesFocus GroupsFutureGeriatric PsychiatryGeriatricsGoalsGovernmentGroup InterviewsGuidelinesHealthHigh PrevalenceInformaticsInterventionInterviewJordanKnowledgeLearningMentored Research Scientist Development AwardMentorsMethodsModelingMonitorMood stabilizersNational Institute on AgingNurse PractitionersNursesNursing HomesOutcomePatient MonitoringPatientsPerceptionPharmaceutical PreparationsPharmacistsPharmacoepidemiologyPhysiciansPilot ProjectsPsychotropic DrugsPublic HealthReportingResearchResearch ActivityResearch MethodologyResearch TrainingRiskRisk FactorsSafetyScienceSeriesSolidSyndromeSystemTrainingTraining ActivityTraining SupportTranslatingUnited StatesUniversitiesVentWorkbasebiomedical informaticscareercareer developmentcomparativecomparative effectivenessdesigneffective interventioneffectiveness researchelectronic dataexperiencefall riskfallshigh riskhypnoticimprovedinnovationinterdisciplinary approachprofessorprognosticprototypesedativetherapy design
项目摘要
DESCRIPTION (provided by applicant): Richard D. Boyce, PhD is an Assistant Professor of Biomedical Informatics at the University of Pittsburgh. He has training in informatics, pharmacoepidemiology, and comparative effectiveness research as well as a strong commitment to improving medication safety for older adults. His prior work has focused on artificial intelligence methods for predicting drug-drug interactions and the comparative safety of
antidepressants for treating de- pressed nursing home residents. The current proposal is for a three year Mentored Research Scientist Development Award (K01) from the National Institute on Aging for training and support that will address gaps in his knowledge of aging research and the nursing home setting. In collaboration with his mentoring team (Drs. Charles Reynolds, Jordan Karp, and Steven Handler) he has developed a training and research plan that will both fill in these knowledge gaps and prepare him for an independent research career. The overarching goal of his K01 is to become an expert on how to effectively translate research results from pharmacoepidemiology and comparative effectiveness research to informatics interventions that improve medication safety for older adults, especially nursing home residents. To accomplish this goal, he proposes eight career development activities and two research aims that will help him 1) obtain rigorous training in the science and practice of creating clinical decision support interventions that are effective in the nursing home setting; 2) obtain a thorough understanding of how falls and fall risk factors are detected, monitored, reported, and assessed in the nursing home setting; and 3) learn the perceptions of multiple nursing home clinician stakeholders on what research is needed to help reduce medication-related adverse events. The two research aims will enable him to integrate and apply the knowledge that he will gain through the proposed training activities by exploring the feasibility and potential clinical usefulness of actively monitoring patients exposed to psycho- tropic PDDIs. The approach would use electronic data available in most United States (US) NHs to provide highly specific and actionable alerts to physicians and/or nurses when a resident who is exposed to a PDDI involving a psychotropic drug transitions to a state of unacceptably high risk for experiencing a fall. Dr. Boyce's hypothesis is that this approach will extend the ability of NH clinicians to perform the recommended "diligent monitoring" of PDDIs, while avoiding alert fatigue. He anticipates that the approach would be generalizable to other prevalent NH ADEs (e.g., delirium) and other drug classes (e.g., mood stabilizers). This proposal is relevant to public health because it will explore an innovative approach to managing PDDIs that may ultimately re- duce the occurrence of one of the most prevalent multifactorial geriatric syndromes (falls). It wil also inform an R-series grant proposal to study a mature intervention that Dr. Boyce plans to submit in year 2 of the project.
描述(由申请人提供):Richard D.博伊斯博士是匹兹堡大学生物医学信息学助理教授。他接受过信息学、药物流行病学和比较有效性研究方面的培训,并坚定地致力于改善老年人的用药安全。他之前的工作主要集中在预测药物相互作用的人工智能方法以及药物的相对安全性。
用于治疗疗养院居民抑郁症的抗抑郁药。目前的提案是由国家老龄化研究所颁发的为期三年的指导研究科学家发展奖(K 01),用于培训和支持,以解决他在老龄化研究和养老院环境知识方面的差距。在与他的导师团队(查尔斯·雷诺兹博士,乔丹·卡普和史蒂芬·诺伊斯)的合作中,他制定了一个培训和研究计划,既填补了这些知识空白,又为他的独立研究生涯做好了准备。他的K 01的总体目标是成为如何有效地将药物流行病学和比较有效性研究的研究结果转化为信息学干预措施的专家,以提高老年人,特别是养老院居民的用药安全性。为了实现这一目标,他提出了八个职业发展活动和两个研究目标,这将有助于他1)获得严格的培训,在科学和实践中创造临床决策支持干预措施,是有效的护理之家设置; 2)获得一个全面的了解如何福尔斯和跌倒风险因素的检测,监测,报告,并在护理之家设置评估;以及3)了解多个护理之家临床医生利益相关者对需要进行哪些研究以帮助减少药物相关不良事件的看法。这两个研究目标将使他能够整合和应用他将通过探索主动监测暴露于精神性PDDI的患者的可行性和潜在临床用途,通过拟议的培训活动获得的知识。该方法将使用大多数美国(US)NH中可用的电子数据,当暴露于涉及精神药物的PDDI的居民转变为经历跌倒的不可接受的高风险状态时,向医生和/或护士提供高度具体和可操作的警报。博伊斯博士的假设是,这种方法将扩展NH临床医生执行推荐的PDDI“勤奋监测”的能力,同时避免警觉疲劳。他预计,这种方法将推广到其他流行的NH ADE(例如,谵妄)和其它药物类别(例如,情绪稳定剂)。该提案与公共卫生相关,因为它将探索一种管理PDDI的创新方法,最终可能减少最常见的多因素老年综合征(福尔斯)之一的发生。它还将通知R系列赠款提案,以研究博伊斯博士计划在项目第二年提交的成熟干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard David Boyce其他文献
Richard David Boyce的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard David Boyce', 18)}}的其他基金
Addressing gaps in clinically useful evidence on drug-drug interactions
解决药物间相互作用的临床有用证据的差距
- 批准号:
9213391 - 财政年份:2014
- 资助金额:
$ 11.44万 - 项目类别:
Addressing gaps in clinically useful evidence on drug-drug interactions
解决药物间相互作用的临床有用证据的差距
- 批准号:
8614005 - 财政年份:2014
- 资助金额:
$ 11.44万 - 项目类别:
Improving medication safety for nursing home residents prescribed psychotropic dr
提高疗养院居民精神药物处方的用药安全
- 批准号:
8776906 - 财政年份:2013
- 资助金额:
$ 11.44万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 11.44万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 11.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 11.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.44万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 11.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.44万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 11.44万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 11.44万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 11.44万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 11.44万 - 项目类别:
Standard Grant